INHIBITION OF NITRIC-OXIDE FORMATION AND PREVENTION OF TYPE-1 DIABETES - RESPONSE

[1] Papaccio G., Esposito V., Latronico M.V.G., Pisanti F.A., Administration of a nitric oxide synthase inhibitor does not suppress low-dose streptozocin-induced diabetes in mice, Int. J. Pancr., (1995)

[2] Holstad M., Sandier S., Aminoguanidine, an inhibitor of nitric oxide formation, fails to protect against insulitis and hyperglycemia induced by multiple low dose streptozotocin injections in mice, Autoimmunity, 15, pp. 311-314, (1993)

[3] Welsh N., Eizirik D.L., Sandier S., Nitric oxide and pancreatic β-cell destruction in insulin dependent diabetes mellitus: Don't take NO for an answer, Autoimmunity, 18, pp. 285-290, (1994)

[1] Papaccio G., Esposito V., Latronico M.V.G., Pisanti F.A., Administration of a nitric oxide synthase inhibitor does not suppress low-dose streptozocin-induced diabetes in mice, Int. J. Pancr., (1995)

[2] Holstad M., Sandier S., Aminoguanidine, an inhibitor of nitric oxide formation, fails to protect against insulitis and hyperglycemia induced by multiple low dose streptozotocin injections in mice, Autoimmunity, 15, pp. 311-314, (1993)

[3] Welsh N., Eizirik D.L., Sandier S., Nitric oxide and pancreatic β-cell destruction in insulin dependent diabetes mellitus: Don't take NO for an answer, Autoimmunity, 18, pp. 285-290, (1994)